company background image
4553 logo

Towa Pharmaceutical TSE:4553 Stock Report

Last Price

JP¥3.06k

Market Cap

JP¥149.4b

7D

0.7%

1Y

70.3%

Updated

23 Jul, 2024

Data

Company Financials +

Towa Pharmaceutical Co., Ltd.

TSE:4553 Stock Report

Market Cap: JP¥149.4b

Towa Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Towa Pharmaceutical
Historical stock prices
Current Share PriceJP¥3,055.00
52 Week HighJP¥3,240.00
52 Week LowJP¥1,769.00
Beta0.0046
11 Month Change6.74%
3 Month Change8.91%
1 Year Change70.29%
33 Year Change10.01%
5 Year Change9.11%
Change since IPO32.97%

Recent News & Updates

Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Jul 03
Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Recent updates

Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Jul 03
Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Shareholder Returns

4553JP PharmaceuticalsJP Market
7D0.7%-1.8%-2.3%
1Y70.3%16.5%21.0%

Return vs Industry: 4553 exceeded the JP Pharmaceuticals industry which returned 16.5% over the past year.

Return vs Market: 4553 exceeded the JP Market which returned 21% over the past year.

Price Volatility

Is 4553's price volatile compared to industry and market?
4553 volatility
4553 Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement3.7%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.8%

Stable Share Price: 4553 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4553's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19514,588Itsuro Yoshidawww.towayakuhin.co.jp

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services.

Towa Pharmaceutical Co., Ltd. Fundamentals Summary

How do Towa Pharmaceutical's earnings and revenue compare to its market cap?
4553 fundamental statistics
Market capJP¥149.38b
Earnings (TTM)JP¥16.17b
Revenue (TTM)JP¥227.93b

9.3x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4553 income statement (TTM)
RevenueJP¥227.93b
Cost of RevenueJP¥146.55b
Gross ProfitJP¥81.38b
Other ExpensesJP¥65.21b
EarningsJP¥16.17b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 08, 2024

Earnings per share (EPS)328.58
Gross Margin35.70%
Net Profit Margin7.10%
Debt/Equity Ratio132.3%

How did 4553 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

18%

Payout Ratio

Does 4553 pay a reliable dividends?

See 4553 dividend history and benchmarks
When do you need to buy 4553 by to receive an upcoming dividend?
Towa Pharmaceutical dividend dates
Ex Dividend DateSep 27 2024
Dividend Pay DateDec 02 2024
Days until Ex dividend65 days
Days until Dividend pay date131 days

Does 4553 pay a reliable dividends?

See 4553 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.